NextFin news, The Trump administration on Thursday, October 2, 2025, launched a broad campaign targeting deals with dozens of industries, including pharmaceuticals, artificial intelligence, energy, and mining, to bolster U.S. manufacturing ahead of the November midterm elections. The initiative aims to strengthen domestic production, reduce supply chain vulnerabilities, and create jobs.
Key pharmaceutical companies such as Eli Lilly and Pfizer have been approached to increase production of critical drugs. Eli Lilly was asked to ramp up insulin manufacturing, while Pfizer was urged to boost output of its leading cancer drug Ibrance and cholesterol medication Lipitor. These efforts are part of a wider strategy to onshore manufacturing and lower drug prices for American consumers.
In addition to pharmaceuticals, the administration is engaging with AI firms to develop domestic capabilities in emerging technologies, and with energy and mining companies to secure raw materials and energy resources vital for manufacturing growth. These sectors are considered essential to national security and economic competitiveness.
The administration’s push includes the use of tariffs and incentives to encourage companies to shift production back to the United States. For example, a 25% tariff on imported heavy trucks and parts was implemented on October 1, 2025, to protect domestic manufacturers such as Peterbilt, Kenworth, and Freightliner, according to statements from the White House and industry sources.
Officials cited national security concerns and the need to reduce dependence on foreign supply chains as primary reasons for the aggressive industrial policy. The administration is leveraging executive powers under the Trade Expansion Act of 1962 to impose tariffs and negotiate agreements that favor U.S. manufacturing interests.
Industry responses have been mixed. While some manufacturers welcome the protection and incentives, others express concern about increased costs and supply chain disruptions. Truck makers, for instance, are awaiting further details on tariff implementation, especially regarding parts sourced from Mexico and Canada under the USMCA trade agreement.
The timing of these initiatives is politically significant, as the administration seeks to demonstrate economic leadership and job creation ahead of the midterm elections scheduled for early November 2025. The deals and tariffs are intended to showcase a commitment to American industry and economic sovereignty.
White House officials, speaking on condition of anonymity, emphasized that these efforts are designed to create a more resilient and competitive manufacturing sector in the United States, reduce drug prices, and ensure that American workers benefit from increased domestic production.
As negotiations continue, the administration plans to announce further agreements with additional companies across various sectors in the coming weeks, aiming to solidify its economic agenda before the elections.
Explore more exclusive insights at nextfin.ai.
